The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
SynKIR-CAR T cell advanced research (STAR)-101 phase 1 clinical trial for patients with advanced mesothelin-expressing ovarian cancer, mesothelioma, or cholangiocarcinoma.
 
Janos Tanyi
No Relationships to Disclose
 
Andrew Haas
Stock and Other Ownership Interests - Serpex Medical
Consulting or Advisory Role - Novocure; Olympus; Serpex Medical
 
Mark O'Hara
Consulting or Advisory Role - Alligator Bioscience; Geneos; Merus; Natera; PsiOxus Therapeutics; Strike Bio
Research Funding - Arcus Biosciences (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); Geistlich Pharma (Inst); Genmab (Inst); HiberCell (Inst); Lilly (Inst); Merck (Inst); Natera (Inst); Parker Institute for Cancer Immunotherapy (Inst); PsiOxus Therapeutics (Inst); Revolution Medicines (Inst)
Patents, Royalties, Other Intellectual Property - 23-10471: Methods Of Treating Cancer Using Soluble ?-Glucans and Cd40 Agonistic Monoclonal Antibodies
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Mehmet Altan
Consulting or Advisory Role - AstraZeneca; BMS; GlaxoSmithKline; InSightec; Lyell Immunopharma; Regeneron
Speakers' Bureau - Nektar
Research Funding - Adaptimmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Jounce Therapeutics (Inst); Lilly (Inst); Lyell Immunopharma (Inst); Merck (Inst); Nektar (Inst); Novartis (Inst); Shattuck Labs (Inst); verismo (Inst)
Travel, Accommodations, Expenses - Nektar
Other Relationship - Hengenix; Nanobiotix (Inst)
 
Zhubin Gahvari
Honoraria - Curio Science; OncLive/MJH Life Sciences
 
Raed Al-Rajabi
Stock and Other Ownership Interests - Actinium Pharmaceuticals; Seagen
Consulting or Advisory Role - AstraZeneca; Bayer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Lexicon (Inst); Lilly (Inst); Merck (Inst); Sillajen (Inst)
 
Daniel Sterman
No Relationships to Disclose
 
Michael Milone
Employment - University of Pennsylvania
Stock and Other Ownership Interests - Cabaletta Bio; Verismo Therapeutics
Consulting or Advisory Role - Cabaletta Bio; Verismo Therapeutics
Research Funding - Verismo Therapeutics
Patents, Royalties, Other Intellectual Property - I am an inventor on multiple patents related to CAR T cell technology licensed to Verismo Therapeutics.
 
Susan Howard
Stock and Other Ownership Interests - Adaptimmune (I); GlaxoSmithKline (I)
 
Emily Winters
Employment - passage bio; Verismo Therapeutics
Stock and Other Ownership Interests - passage bio
 
Andrea Campanile
No Relationships to Disclose
 
Jun Xu
Employment - Verismo Therapeutics
 
Laura Johnson
Employment - Verismo Therapeutics
Stock and Other Ownership Interests - Verismo Therapeutics
Research Funding - Verismo Therapeutics
Patents, Royalties, Other Intellectual Property - Patents involving CAR T therapy through the University of Pennsylvania